Graft versus Host Disease (GVHD) - Market Insights, Epidemiology and Market Forecast-2023- Japan

Publisher Name :
Date: 01-Nov-2016
No. of pages: 40
This report is available at upto 40% Discount. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Graft versus Host Disease (GVHD) - Market Insights, Epidemiology and Market Forecast-2023-Japan" report provides an overview of the disease and global historical and forecasted epidemiological data for the diagnosed incident cases of Hematopoietic stem cell transplantations (HSCTs) and Graft Versus Host Disease (GVHD) based upon the sub-types of GVHD along with the type of donor involved in the HSCTs, for the forecast period (2013-2023). The report also includes global market size of the Graft Versus Host Disease (GVHD) for Japan.

GVHD is one of the severe complications associated with Hematopoietic stem cell transplantations (HSCTs). DelveInsight forecasts predict an on-going increase in HSCTs in the near future which shall lead to subsequent increase in the patient population of GVHD. According to DelveInsight's estimates, the total number of diagnosed incident cases of Hematopoietic Stem Cell Transplants (HSCTs) shall increase at a Compound Annual Growth Rate (CAGR) of 2.73% from 2013-2023 and reach up to 7,025 cases in the year 2023.

The incident rate of GVHD in unrelated donor (URD) is much higher in comparison to the sibling donors (SD), irrespective of the sub-types i.e., acute GVHD (aGVHD) or chronic GVHD (cGVHD). As per DelveInsight forecasts, the diagnosed incidence cases of aGVHD in sibling donors and aGVHD in unrelated donors, shall increase at a CAGR of 2.88 % and 1.57%, respectively, from 2013-2023. In case of cGVHD, the number of diagnosed incident population cGVHD in sibling donors and cGVHD in unrelated donors is expected to accentuate at a CAGR of 2.88% and 1.57%, respectively, by the end of the year 2023.

The market size of GVHD mainly comprises of the off-label biologics. Many companies are working on the development of targeted therapy and in the near future, these drugs may create an impact on the overall market size of GVHD. DelveInsight's estimates suggest that the forecasted market size of Graft Versus Host Disease (GVHD) in Japan shall increase at a CAGR of 4.80% from 2013 to 2023.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Scope

- Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.

- It focuses on the risk factors and the historical trends of the diagnosed incident cases of allogeneic Hematopoietic Stem Cell Transplants (HSCTs) ( which also includes the cases of first transplants along with the total transplants)

- The Report also covers the detailed historical and forecasted number of diagnosed incident cases of acute GVHD and chronic GVHD, segmented by the type of donors (Sibling donors and unrelated donors) for Japan from 2013-2023.

- The Report also includes historical and forecasted Market size of GVHD for Japan from 2013 to 2023.

- It provides the information of available marketed therapies, including off-label biologics, patent and exclusivity details.

- The report also focuses on the details of pipeline drugs in the pivotal stage of development including their SWOT Analysis and expected launch date, which shall help to predict the impact of those drugs on the market size in the near future.

Graft versus Host Disease (GVHD) - Market Insights, Epidemiology and Market Forecast-2023- Japan

Table of Contents

Graft Versus Host Disease (GVHD)
Disease Definition
Disease Types
Acute GVHD
Chronic GVHD
Grades of GVHD
Pathophysiology
Risk Factors for GVHD
Diagnosis
Epidemiology and Patient Population
Key Points
Diagnosed Incident Cases of Hematopoietic Stem Cell Transplantations (HSCTs) in Japan
Diagnosed Incident Cases of aGVHD in Diagnosed Incident Cases of First Allogeneic HSCTs in Japan
Diagnosed Incident Cases of cGVHD in Diagnosed Incident Cases of First Allogeneic HSCTs in Japan
Assumptions and Rationale
Treatment Algorithm
Guidelines and Recommendations for Treatment of GVHD in Japan
Current Unmet Needs of Graft Versus Host Disease (GVHD)
Marketed Drugs
Temcell HS
Regulatory Milestones
Advantages & Disadvantages
Product Profile
Safety and Efficacy of Temcell HS
Side effects of Temcell HS
SWOT Analysis of Temcell HS
Remicade
Regulatory Milestones
Advantages & Disadvantages
Product Profile
Safety and Efficacy of Remicade
Side effects of Remicade
SWOT Analysis
Lemtrada
Regulatory Milestones
Advantages & Disadvantages
Product Profile
Safety and Efficacy of Lemtrada
Adverse reactions of Lemtrada
SWOT Analysis
Velcade
Regulatory Milestones
Advantages & Disadvantages
Product Profile
Safety and Efficacy of Velcade
Side effects of Velcade
SWOT Analysis
Gleevec
Regulatory Milestones
Advantages & Disadvantages
Product Profile
Safety and Efficacy of Gleevec
Adverse reactions of Gleevec
SWOT Analysis
Rapamune
Regulatory Milestones
Advantages & Disadvantages
Product Profile
Safety and Efficacy of Rapamune
Adverse reactions of Rapamune
SWOT Analysis
Simulect
Regulatory Milestones
Advantages and Disadvantages
Product Profile
Safety and Efficacy of Simulect
Side effects of Simulect
SWOT Analysis
Enbrel
Regulatory Milestones
Advantages and Disadvantages
Product Profile
Safety and Efficacy of Enbrel
Side effects of Enbrel
SWOT Analysis
Orencia
Regulatory Milestones
Advantages and Disadvantages
Product Profile
Safety and Efficacy of Orencia
Side effects of Orencia
SWOT Analysis
Nulojix
Regulatory Milestones
Advantages and Disadvantages
Product Profile
Safety and Efficacy of Nulojix
Side effects of Orencia
SWOT Analysis
Emerging Drugs Analysis
Emerging Drugs
Begelomab
Regulatory Milestones
Clinical Development
Product Profile
Clinical Pipeline Activity
Ongoing Trials Information
Clinical Trial by Phase
SWOT Analysis
Budesonide
Regulatory Milestones
Clinical Development
Product Profile
Clinical Pipeline Activity
Ongoing Trials Information
Clinical Trial by Phase
SWOT Analysis
Methoxsalen
Regulatory Milestones
Clinical Development
Product Profile
Clinical Pipeline Activity
Ongoing Trials Information
Clinical Trial by Phase
SWOT Analysis
Market Size
Japan
Total Market Size of GVHD
Market Size of GVHD by Treatment Type
Market Drivers
Market Barriers
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

List of Tables

Table 1: Diagnosed Incident Cases of Hematopoietic Stem Cell Transplantations (HSCTs) in Japan (2013-2023)
Table 2: Diagnosed Incident Cases of aGVHD in Diagnosed Incident Cases of First Allogeneic HSCTs in Japan (2013-2023)
Table 3: Diagnosed Incident Cases of cGVHD in Diagnosed Incident Cases of First Allogeneic HSCTs in Japan (2013-2023)
Table 4: GVHD Prophylaxis regimen for Myeloablative conditioning
Table 5: GVHD Prophylaxis regimen for Reduced intensity conditioning
Table 6: Begelomab, Clinical Trials by Zone, 2016
Table 7: Clinical Trials by Recruitment status, 2016
Table 8: Budesonide, Clinical Trials by Zone, 2016
Table 9: Clinical Trials by Recruitment status, 2016
Table 10:Methoxsalen, Clinical Trials by Zone, 2016
Table 11: Clinical Trials by Recruitment status, 2016
Table 12: Japan market size of GVHD in USD, Million (2013-2023)
Table 13: Japan market size of GVHD by treatment type in USD, Million (2013-2023)

List of Figures

Figure 1: Pathophysiology of GVHD
Figure 2: Risk Factors for GVHD
Figure 3: Diagnosed Incident Cases of Hematopoietic Stem Cell Transplantations (HSCTs) in Japan (2013-2023)
Figure 4: Diagnosed Incident Cases of aGVHD in Diagnosed Incident Cases of First Allogeneic HSCTs in Japan (2013-2023)
Figure 5: Diagnosed Incident Cases of cGVHD in Diagnosed Incident Cases of First Allogeneic HSCTs in Japan (2013-2023)
Figure 6: Treatment Algorithm of GVHD
Figure 7: Begelomab, Clinical Trials by Zone (%), 2016
Figure 8: Begelomab, Clinical Trials by Recruitment status (%), 2016
Figure 9: Budesonide, Clinical Trials by Zone (%), 2016
Figure 10: Budesonide, Clinical Trials by Recruitment status (%), 2016
Figure 11: Methoxsalen, Clinical Trials by Zone (%), 2016
Figure 12: Methoxsalen, Clinical Trials by Recruitment status (%), 2016
Figure 13: Spain market size of GVHD in USD, Million (2013-2023)
Figure 14: Japan market size of GVHD in USD, Million (2013-2023)
Figure 15: Japanmarket size of GVHD by treatment type in USD, Million (2013-2023)
  • Global Oxycodone Hydrochloride Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 07-Dec-2016        Price: US 3480 Onwards        Pages: 111
    Oxycodone hydrochloride is a white, odorless crystalline powder derived from the opium alkaloid, thebaine. Oxycodone hydrochloride dissolves in water (1 g in 6 to 7 mL) and is considered slightly soluble in alcohol (octanol water partition coefficient is 0.7). Scope of the Report: This report focuses on the Oxycodone Hydrochloride in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market......
  • Global Codeine Phosphate Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 06-Dec-2016        Price: US 3480 Onwards        Pages: 113
    Codeine phosphate is a type of medicine called an opioid. Codeine is a mild painkiller, but also has cough suppressant and anti-diarrhoeal actions. Scope of the Report: This report focuses on the Codeine Phosphate in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report co......
  • Global Anti-Infective Drugs Sales Market Report 2016
    Published: 05-Dec-2016        Price: US 4000 Onwards        Pages: 114
    Notes: Sales, means the sales volume of Anti-Infective Drugs Revenue, means the sales value of Anti-Infective Drugs This report studies sales (consumption) of Anti-Infective Drugs in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - GlaxoSmithKline - Merck - Pfizer - Novartis AG ......
  • Global Simethicone Market Research Report 2016
    Published: 05-Dec-2016        Price: US 2900 Onwards        Pages: 109
    Notes: Production, means the output of Simethicone Revenue, means the sales value of Simethicone This report studies Simethicone in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Basildon Chemicals - RioCare India Pvt. Ltd. - Dow Corning S.A. - Wacker - NuSil......
  • Global Human Immunoglobulin Market Research Report 2016
    Published: 05-Dec-2016        Price: US 2900 Onwards        Pages: 114
    Notes: Production, means the output of Human Immunoglobulin Revenue, means the sales value of Human Immunoglobulin This report studies Human Immunoglobulin in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Baxter - CSL - Grifols - Octapharma - Biotest - ......
  • Global Penicillin Market Professional Survey Report 2016
    Published: 02-Dec-2016        Price: US 3500 Onwards        Pages: 112
    Notes: Production, means the output of Penicillin Revenue, means the sales value of Penicillin This report studies Penicillin in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each ma......
  • Global Codeine Phosphate Market Research Report 2016
    Published: 02-Dec-2016        Price: US 2900 Onwards        Pages: 111
    Notes: Production, means the output of Codeine Phosphate Revenue, means the sales value of Codeine Phosphate This report studies Codeine Phosphate in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Macfarian Smith - Francopia - Noramco - Weifa - Mallinckrodt......
  • Global Buprenorphine Hydrochloride Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 02-Dec-2016        Price: US 3480 Onwards        Pages: 113
    Buprenorphine hydrochloride, a white crystalline powder, is a semisynthetic opioid analgesic used for the relief of moderate to severe pain. It is in the same chemical family of morphine, codeine and heroin. However, buprenorphine hydrochloride has the distinction of producing less euphoric effects than those drugs.Scope of the Report:This report focuses on the Buprenorphine Hydrochloride in Global market, especially in North America, Europe and Asia-Pacific, South America......
  • Europe Varicella Vaccine Market Report 2016
    Published: 02-Dec-2016        Price: US 3900 Onwards        Pages: 129
    Notes: Sales, means the sales volume of Varicella Vaccine Revenue, means the sales value of Varicella Vaccine This report studies sales (consumption) of Varicella Vaccine in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - GSK - Sanofi-Pasteur - Merck - CSL Biotherapies......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs